The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc. Life Science Investing
Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome in Europe Life Science Investing
RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting Life Science Investing
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 Life Science Investing
Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit Life Science Investing
NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration Life Science Investing
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026 Life Science Investing
